Dashenlin Pharm Grp Co Ltd (603233) - Total Liabilities

Latest as of September 2025: CN¥17.59 Billion CNY ≈ $2.57 Billion USD

Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has total liabilities worth CN¥17.59 Billion CNY (≈ $2.57 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dashenlin Pharm Grp Co Ltd cash flow conversion to assess how effectively this company generates cash.

Dashenlin Pharm Grp Co Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how Dashenlin Pharm Grp Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Dashenlin Pharm Grp Co Ltd to evaluate the company's liquid asset resilience ratio.

Dashenlin Pharm Grp Co Ltd Competitors by Total Liabilities

The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Vapores SN:VAPORES	Chile	CL$62.81 Million
Marathon Digital Holdings Inc NASDAQ:MARA	USA	$3.98 Billion
Shaanxi Huaqin Technology Industry Co. Ltd. A SHG:688281	China	CN¥1.66 Billion
Angel One Limited NSE:ANGELONE	India	Rs125.10 Billion
Bank of Hawaii Corporation NYSE:BOH	USA	$22.33 Billion
Wuxi Taiji Industry Co Ltd SHG:600667	China	CN¥23.98 Billion
Dyne Therapeutics Inc NASDAQ:DYN	USA	$214.83 Million
Enerjisa Enerji AS IS:ENJSA	Turkey	TL114.06 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Dashenlin Pharm Grp Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Dashenlin Pharm Grp Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.67	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dashenlin Pharm Grp Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dashenlin Pharm Grp Co Ltd (2012–2024)

The table below shows the annual total liabilities of Dashenlin Pharm Grp Co Ltd from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥18.30 Billion ≈ $2.68 Billion	+13.04%
2023-12-31	CN¥16.19 Billion ≈ $2.37 Billion	+15.83%
2022-12-31	CN¥13.98 Billion ≈ $2.05 Billion	+22.61%
2021-12-31	CN¥11.40 Billion ≈ $1.67 Billion	+68.66%
2020-12-31	CN¥6.76 Billion ≈ $989.06 Million	+55.73%
2019-12-31	CN¥4.34 Billion ≈ $635.11 Million	+25.79%
2018-12-31	CN¥3.45 Billion ≈ $504.89 Million	+14.25%
2017-12-31	CN¥3.02 Billion ≈ $441.93 Million	+34.94%
2016-12-31	CN¥2.24 Billion ≈ $327.50 Million	+36.70%
2015-12-31	CN¥1.64 Billion ≈ $239.58 Million	-8.55%
2014-12-31	CN¥1.79 Billion ≈ $261.98 Million	+64.11%
2013-12-31	CN¥1.09 Billion ≈ $159.64 Million	+77.27%
2012-12-31	CN¥615.39 Million ≈ $90.05 Million	--

About Dashenlin Pharm Grp Co Ltd

SHG:603233 China Biotechnology

Market Cap

$3.11 Billion

CN¥21.26 Billion CNY

Market Cap Rank

#4859 Global

#922 in China

Share Price

CN¥18.67

Change (1 day)

-0.27%

52-Week Range

CN¥15.58 - CN¥21.27

All Time High

CN¥57.53